Artificial Saliva Market Report 2025

This Artificial Saliva market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The artificial saliva market size has grown rapidly in recent years. It will grow from $1.95 billion in 2024 to $2.22 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth in the historic period can be attributed to growing demand for oral sprays, oral gels, and oral liquids, expanding treatment options for cancer patients, growing aging population, rising disposable income, rise in dental disorders among individuals worldwide.

The artificial saliva market size is expected to see rapid growth in the next few years. It will grow to $3.72 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to growing awareness about the importance of oral hygiene, escalating prevalence of dry mouth syndrome (xerostomia), increasing demand for artificial saliva, rising incidents of cancer, prevalence of cancer and surge in chemotherapy treatment. Major trends in the forecast period include increasing R and D activities, advancements in product formulation, integration with advanced technologies, technological developments in dry mouth treatment, shift towards natural and biocompatible ingredients.

The increasing prevalence of dry mouth syndrome is expected to drive growth in the artificial saliva market. Dry mouth syndrome, or xerostomia, is characterized by persistent mouth dryness, exacerbated by factors such as aging and the widespread use of medications. Artificial saliva helps moisturize oral tissues, alleviating the discomfort associated with xerostomia. For instance, a study by Faculdade Meridional found a 19.1% prevalence of xerostomia among 293 older adults in Brazil in 2021. Similarly, research by the University of Gothenburg reported a 43.6% prevalence among 374 adult patients seeking primary healthcare in 2022. These trends underscore the role of rising xerostomia cases in fueling demand for artificial saliva.

The growing burden of cancer is expected to drive the growth of the artificial saliva market in the coming years. Cancer is a condition in which abnormal cells grow uncontrollably, potentially leading to death if untreated. The rising incidence of cancer is influenced by factors such as an aging population, lifestyle changes, increased exposure to risk factors, and improved detection methods. Artificial saliva provides relief for dry mouth in cancer patients undergoing treatments like chemotherapy or radiation, which can reduce natural saliva production, improving comfort and supporting oral health. For example, in August 2024, a report from the Australian Institute of Health and Welfare, an Australian national agency for health and welfare statistics, projected that by 2034, Australia will see approximately 209,000 new cancer diagnoses, up from an estimated 169,000 cases in 2024. This increase reflects the impact of a growing population and rising cancer rates. Additionally, in 2024, cancer is expected to account for about 3 out of every 10 deaths in Australia.

In March 2023, Hologram Sciences collaborated with Haleon to develop personalized health products, leveraging Haleon's expertise in consumer healthcare. Haleon, known for science-backed solutions, offers artificial saliva products that address dry mouth and support oral health, aligning with the market's growing needs.

Major companies operating in the artificial saliva market are Pfizer Inc., Amgen Inc., Viatris Inc., Bausch Health Companies Inc., Perrigo Company plc, Aurobindo Pharma, Cipla, Hikma Pharmaceuticals plc, RECORDATI, Mankind Pharma Ltd., Quantum Health Inc., Mission Pharmacal Company, Cumberland Pharmaceuticals Inc., DENTAID, Parnell Pharmaceuticals Inc., Forward Science, ICPA Health Products Ltd., Saliwell Ltd., Livealth, CCMed Ltd., Nanochemazone.

North America was the largest region in the artificial saliva market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial saliva market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial saliva market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Artificial saliva is a synthetic product created to replicate the functions of natural saliva, primarily used to alleviate dry mouth (xerostomia) resulting from conditions such as Sjögren's syndrome, cancer radiation therapy, or certain medications. It helps by moisturizing and lubricating the mouth, facilitating chewing and swallowing, and enhancing oral comfort.

The main types of artificial saliva products include oral spray, oral solution, oral liquid, dissolving tablets, gel, and powder. Oral spray is formulated as a spray to temporarily relieve dry mouth symptoms by providing lubrication and moisture to the oral cavity. Distribution channels for these products include supermarkets, hypermarkets, and other retail outlets, catering to both adults and children as end-users.

The artificial saliva market research report is one of a series of new reports that provides artificial saliva market statistics, including the artificial saliva industry global market size, regional shares, competitors with artificial saliva market share, detailed artificial saliva market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial saliva industry. These artificial saliva market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial saliva market consists of sales of sprays, gels, and lozenges. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.